INS and Hyperglycemia: The evaluation of a clinical decision tool for non-diabetes specialists for the management of raised glucose (35) saw a reduction in the percentage of patients with hyperglycaemia as their primary reason for admission who then received an intravenous insulin infusion (84% to 56% (P<0.01).